~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
| Unit 6
Stereochemistry Stereoisomers & Chirality
|
![]() |
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Stereoisomers
Stereochemistry
is the study of the 3-dimensional
structure of molecules. Isomers
are molecules with the same chemical formula and often with the same
kinds of bonds between atoms, but in which the spatial arrangement of
atoms differs. Isomers are grouped into two broad classes. (Most of the
non-substituted cycloalkanes have conformational isomers, or
diastereomers also known as conformers.)
If
molecules contain internal planes of symmetry, then their mirror images can be superimposed,
and they are achiral. However, just
because we cannot find an internal plane of symmetry does not mean that molecule
must be chiral (typical examples are aromatic compounds). If
two of the four groups on a carbon atom are the same, then the molecule is not
chiral. A carbon atom with two identical constituents usually has an
internal plane of symmetry which splits the molecule down the middle along the
plane between the 2 common constituents. When rotated by 180 degrees, the mirror
images of such structures can be superimposed on each other. Thus, these type of
molecules are achiral.
Thus, if a compound has no
asymmetric carbon, it is usually achiral. If a compound has just one symmetric
compound, it is chiral. If a compound has more than one asymmetric carbon, it
may or may not be chiral.
This
class includes chiral enantiomers
which are non-superimposable mirror-images of each other, as well as diastereomers
which are not mirror images. Thus, diastereomers
are stereoisomers
that are not mirror images. This
group can be subdivided into conformational
isomerism (conformers) when isomers can interconvert by chemical bond
rotations and cis-trans isomerism
when this is not possible. (Note: Although conformers can be referred to as
having a diastereomeric relationship, these isomers
over all are not diastereomers, since bonds in conformers can be rotated to
make them mirror images.) Most
diastereomers contain 2 or more chirality centers.

Fischer projections that differ by a 180 degree
rotation are the same. This is due to the fact that the vertical lines
remain forward, and the horizontal lines remain recessed into the page.
Alternatively, 90 degree rotations change the spatial characteristics of the
molecule by switching the forward and reverse arrangements of the chiral center.
This typically results in a chiral enantiomer of the original configuration.
(Flipping them over has a similar effect).
The mirror image of a Fischer projection is created simply by
interchanging the groups on the horizontal part of the cross. This effectively
reverses left and right, while leaving the vertical portion of the configuration
unchanged.
| "Enantiomers are conformations of the same molecule whose mirror images cannot be superimposed on one another." | ![]() |
Testing for chirality (and thus
enantiomerism) is particularly simple using Fischer projections. If the mirror
image cannot be made to look the same as the original structure with a 180
degree rotation in the plane of the paper, the two mirror images are
enantiomers. If the original structure can be obtained using a 180 degree
rotation of the mirror image, then the structure is achiral.
Mirror planes of symmetry are particularly easy to identify using Fischer
projections. Molecules with symmetry planes cannot be chiral.
Diastereomers are
stereoisomers not related through a reflection operation. These often have
multiple chiral centers, and include meso compounds, cis-trans (E-Z)
isomers, and non-enantiomeric optical isomers. Diastereomers seldom have the
same physical properties. In the example shown below, the meso form of tartaric
acid (on the right) forms a diastereomeric pair with both levo and dextro
tartaric acids (on the left) , which form an enantiomeric pair.
|
Tartaric Acid |
Applications I: Biochemistry
Stereochemistry is an excellent example of the importance of structural symmetry
in nature. Some 50 % of all organic compounds have chiral centers. E.G. When the
amino acid alanine is synthesized in the laboratory, a mixture of the two
possible structures is formed. However, when alanine is produced in a living
cell, only one of the two forms is seen. The naturally occurring form of alanine
is called L-alanine, and its mirror image is called D-alanine. Comparison of the
20 common amino acids will show that only the "L" form is used in protein
synthesis.
http://web.mit.edu/esgbio/www/chem/stereo.html
Receptors have a distinct three-dimensional structure whose surface consists of
grooves and cavities. They can interact only with three-dimensional molecules
which have a complementary structure. Depending on the form of the molecule that
links to the receptor, the biological results may vary significantly.
Thus, receptors usually display of preference for binding a specific structure.
Through selective metabolism, a membrane can also displace selective intake by
providing a specific transport mechanism that only recognizes only a single
enantiomer. Toxic effects include non-specific receptors that can bind the drug,
thus lowering the available concentration for specific receptors.
The enzymatic machinery used in protein synthesis has an asymmetric binding site
the amino acids must fit into. Your right hand won't fit properly into a left
handed glove, and an amino acid of the wrong shape won't fit into an enzyme. Of
all the naturally occurring amino acids in proteins, only Glycine (NH2-CH2-COOH)
has a plane of symmetry (along its "spine").
Our bodies only create and digest carbohydrates and amino acids of a certain
stereochemistry. Thus, all the proteins that make up our hair, skin, organs,
brain, and tissues, are composed of a single stereoisomer of amino acids. We can
synthesize and digest starch (e.g. bread & potatoes) but not wood pulp or
cellulose (plant fibers) even though both are stereoisomers of polymerized
glucose.
Stereochemistry is also very important from the point of view of synthetic
pharmaceuticals and their mechanism of action in the body. Since so many
biochemical compounds consist of stereoisomers (e.g. amino acids, nucleotides,
carbohydrates & phospholipids) it makes sense that synthetic drugs also have
chiral centers. But while one stereoisomer may have positive effects on the
body, another stereoisomer may be toxic -- or even lethal.
Thus, a drug upon administration undergoes a series of steps (aside form
official FDA approval) before exerting its activity. At each step the molecular
structure of the compound and hence its chirality influences the further
metabolism. Because of this, a great deal of work done by synthetic organic
chemists today is in devising methods to synthesize compounds that are purely
one stereoisomer.
http://tigger.uic.edu/~kbruzik/text/chapter4.htm
E.G. Thalidomide was a drug used during the 1950s to suppress morning sickness.
The drug was prescribed as a racemic mixture -- that is, it contained a 50:50
mixture of its mirror images -- and while one stereoisomer of the drug actively
worked on controlling morning sickness, the other stereoisomer caused serious
birth defects. Ultimately the FDA pulled it from the marketplace.
E.G. The binding of Ibuprofin, a common pain reliever. While one stereoisomer of
the compound has the right three-dimensional shape to bind to the protein
receptor, the other does not and can not bind, and is therefore ineffective as a
pain reliever.
http://www.chemhelper.com/biostereo.html
Another example is Vitamin E (an essential component in our immune system) which
contains three asymmetric carbons. This allows for up to eight possible isomeric
structures to be formed. In nature, due to unique specificity, only one form is
produced. In the synthetic formulation, however, all eight forms are created,
thus diluting the natural form to only 12.5% of the vitamin added.
http://www.mazuri.com/Llama-VitaminE.htm?Animal=Llama
The current policies of FDA in drug approval is that the inactive stereoisomer
(or enantiomer) in the racemic drug has to be shown to be devoid of any toxicity
or undesired side-effects.
~~~~~~~~~~~~~~~~~~~~~~~~~~
Eliel, E.E. and Wilen, S.H.
Stereochemistry of Organic Compounds
John Wiley & Sons: NY, NY (1994)
~~~~~~~~~~~~~~~~~~~~~~~~~~~
Applications II: Pharmaceuticals
This note is regarding the
ramifications of racemic mixtures in synthetic pharmaceuticals. According to the
article referenced below (which can be downloaded in PDF format) the 2
enantiomers of a chiral drug may differ significantly in their bioavailability,
rate of metabolism, excretion, potency and selectivity for receptors,
transporters and/or enzymes, and toxicity.
Single-enantiomer formulations of (S)-albuterol (asthma inhibitor: Ventalin,
Proventil) and (S)-omeprazole (acid reflux inhibitor: Prilosec) have both
exhibited superiority to their racemic formulations in clinical trials.
Alternatively, one enantiomer of Sotalol has both beta-blocker and
antiarrhythmic activity, while the other enantiomer has antiarrythmic properties
but lacks beta-adranergic antagonism. In addition, one enantiomer of fluoxetine
(Prozac), at its highest dosage, let to statistically significant prolongation
of cardiac repolarization.
Although many psychotropic drugs are either achiral
[fluvoxamine (Luvox) and nefazodone]
or are already marketed as single enantiomers
[sertraline (Zoloft), paroxetine (Paxil), escitalopram (Lexapro)]
several antidepressants have been marketed as racemates:
[bupropion (Wellbutrin), citalopram (Celexa), fluoxetine (Prozac),
tranylcypromine (Parmate), trimipramine (Surmontil), and vanlafaxine (Effexor)].
Other drugs often used in psychiatric practice (zopiclone, methylphenndate, and
some phenothiazines) are also available as racemates. Of these,
single-enantiomer formulations are being developed for buproprion (Wellbutrin)
and zopiclone, as well as methylphenidate (Ritalin, Concerta) or
d-methylphenidate (Focalin).
In both citalopram and fluoxetine, one enantiomer appeared to have superior in
vivo properties.
In the case of citalopram, the -enantiomer is primarily responsible for
antagonism of seratonin uptake, while the (S)-enantiomer is 30 time less potent.
In clinical trials, both racemic (R,S)-citalopram (Celexa) and the
(S)-enantiomer version (Lexapro) were significantly better than placebo for
improving depression.
In the case of fluoxetine (Prozac), the attempt to develop a single-enantiomer
formulation for the treatment of depression was unsuccessful. While the R and S
enantiomers of fluoxetine are are similarly effective at blocking the uptake of
seratonin, they are metabolized differently. The use of the R enantiomer was
expected to result in less variable plasma levels of fouxetine and its active
metabolites than observed with racemic fluoxetine. In addition, the -fluoxetine
and its metabolites inhibit certain target enzymes to a lesser extent than (S)-fluoxetine
and its metabolites.
As previously mentioned, one enantiomer of fluoxetine, at its highest dosage,
let to statistically significant prolongation of cardiac repolarization (but
studies were terminated). Although racemic fluoxetine has proven to be both safe
and effective for over 15 years, the -enantiomer formulation was not viable due
to safety concerns.
It would appear obvious now that when both a single-enantiomer and a racemic
formulation of a drug are available, the information from both trial and
experience should be used to decide which formulation is most appropriate on a
case-by-case basis.
~~~~~~~~~~~~~~~~~~~
McConathy, J. and Owens, M.
"Stereochemistry in Drug Action"
J. Clinical Psychiatry / Primary Care Companion
Vol 5, p.70 (2003)
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~